Veterinary Market: AI Stethoscope Study Flags Diagnostic Limits

NC State Study Finds AI-Enabled Stethoscope Unreliable for Heart Diagnosis in Cats and Dogs 

RALEIGH, North Carolina, United States  August 21, 2026  A peer-reviewed study from North Carolina State University has found that an AI-enabled digital stethoscope demonstrates significant diagnostic limitations when used on companion animals, raising important questions about the deployment of human-trained AI tools within veterinary clinical settings. The findings carry direct implications for the global Veterinary Market, which was valued at USD 118.73 billion in 2024 and is projected to reach USD 172.76 billion by 2030, growing at a CAGR of 6.5% from 2025 to 2030. 

The prospective study, published online August 5, 2026 in the Journal of the American Veterinary Medical Association, evaluated 105 companion animals 54 dogs and 51 cats comparing cardiac assessments by board-certified veterinary cardiologists, a cardiology resident, and a fourth-year veterinary student against results produced by the AI-enabled stethoscope. The device tested was designed for human use, a distinction the researchers identified as central to its underperformance in veterinary patients. 

"However, the diagnostic AI for these stethoscopes is trained on human data, not dog or cat data," said Kursten Pierce, DVM, DACVIM (Cardiology), FACVIM (Interventional Cardiology), an assistant professor of clinical sciences and board-certified cardiologist at NC State's College of Veterinary Medicine. The study's first author, Jake Johnson, DVM, a cardiology resident at NC State, cautioned that the device's limitations were particularly pronounced in feline patients: "This device essentially couldn't find a murmur, so a tool vets lean on for reassurance could let real disease go undetected." 

Key Highlights: 

• Canine Murmur Detection: The AI system correctly identified 33 of 38 murmurs in dogs, achieving approximately 87% sensitivity comparable to a fourth-year veterinary student but produced unreliable arrhythmia classifications, including false-positive atrial fibrillation findings in dogs with normal rhythms. 

• Feline Performance Gap: Among 51 cats, veterinary clinicians identified murmurs in 22 animals; the AI device detected only 2, missing 20 confirmed murmurs  a critical shortfall with direct patient safety implications. 

• Adjunct Role Recommended: Researchers concluded the device's ECG recording capability offers genuine clinical utility when interpreted by a trained veterinary professional, but its automated diagnostic outputs require significant caution in companion animal settings. 

• Broader Technology Validation Concern: The study highlights a systemic issue with applying AI diagnostic tools outside the populations for which they were developed, underscoring the need for species-specific validation before clinical adoption in veterinary medicine. 

Analyst Insight: 

According to analysts at Next Move Strategy Consulting, the NC State findings reflect a critical gap in the current AI diagnostics landscape within veterinary medicine where technology developed for human healthcare is increasingly being adopted in clinical animal settings without adequate species-specific validation. NMSC analysts note that as the global veterinary market advances toward USD 172.76 billion by 2030, demand for purpose-built, veterinary-specific AI diagnostic tools is expected to intensify, creating a significant commercial opportunity for technology developers who invest in companion animal training datasets and regulatory-grade clinical validation frameworks. 

Industry Outlook: 

The NC State study serves as a timely signal to veterinary technology developers, diagnostic equipment manufacturers, and clinical practitioners that AI-assisted tools must undergo rigorous, species-specific evaluation before being integrated into standard veterinary care protocols. As the veterinary diagnostics segment continues to expand driven by rising pet ownership, growing awareness of companion animal cardiac disease, and increasing investment in point-of-care technologies the demand for validated, veterinary-native AI solutions is expected to grow substantially. 

Regulatory bodies and academic institutions are likely to play an increasingly active role in establishing evidence-based standards for AI tool adoption in veterinary medicine, ensuring that clinical decision support technologies deliver reliable outcomes across the full spectrum of animal patients. 

Source: dvm360

For More Information: Download FREE Sample on Veterinary Market Report

Prepared By: Sanyukta Deb